Green Thumb Industries (OTCMKTS:GTBIF) Raised to “Strong-Buy” at Roth Capital

Posted by Jessica Moore on Nov 12th, 2024

Green Thumb Industries (OTCMKTS:GTBIF – Get Free Report) was upgraded by analysts at Roth Capital to a “strong-buy” rating in a note issued to investors on Sunday,Zacks.com reports.

GTBIF has been the subject of several other reports. Craig Hallum raised shares of Green Thumb Industries to a “strong-buy” rating in a report on Monday, September 16th. Ventum Cap Mkts upgraded shares of Green Thumb Industries to a “strong-buy” rating in a research report on Tuesday, August 6th. Three equities research analysts have rated the stock with a buy rating and three have given a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Strong Buy” and an average target price of $16.50.

Read Our Latest Stock Report on GTBIF

Green Thumb Industries Stock Performance

OTCMKTS GTBIF traded down $1.12 on Friday, hitting $7.80. The stock had a trading volume of 1,941,637 shares, compared to its average volume of 462,275. The firm has a 50-day moving average of $10.26 and a 200-day moving average of $11.14. The company has a market capitalization of $1.65 billion, a price-to-earnings ratio of 28.90 and a beta of 1.40. Green Thumb Industries has a 52-week low of $7.50 and a 52-week high of $16.33.

Green Thumb Industries (OTCMKTS:GTBIF – Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). The firm had revenue of $286.87 million during the quarter, compared to the consensus estimate of $283.96 million. Green Thumb Industries had a return on equity of 3.39% and a net margin of 5.38%. As a group, research analysts anticipate that Green Thumb Industries will post 0.32 earnings per share for the current fiscal year.

Green Thumb Industries Company Profile

(Get Free Report)

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.